“Leucostim”, a treatment for neutropenia, is to be export to Turkey, Dong-A Pharmaceutical has announced on October 28.
It is going to export $20 million's worth of Leucostim to DEM ilac in Turkey for the next five years. Leucostim has recently got the approval for the supply from the health authorities of Iran.
Earlier, Dong-A and DEMilac in Turkey agreed to extend a three-year contract ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.